Thrombotic antiphospholipid syndrome (APS) is characterised by venous, arterial and/or
small vessel thrombosis in the context of persistently positive antiphospholipid antibodies …

The antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized,
according to the Sydney criteria, by the persistent presence of autoantibodies directed …

Interrelationships between periodontal infection and systemic conditions such as
cardiovascular disease, adverse pregnancy outcomes, and head-and-neck cancer have …

Antiphospholipid syndrome (APS) is an acquired thrombophilia with clinical manifestations
associated with the presence of antiphospholipid antibodies (aPL) in patient plasma …

Our previous study demonstrated that Toll-like receptor 4 (TLR4) could act as a co-receptor
with annexin A2 (ANX2) mediating anti-β2-glycoprotein I/β2-glycoprotein I (anti …

Increased mean platelet volume (MPV) is associated with platelet reactivity and is a
predictor of cardiovascular risk and unprovoked venous thromboembolism. The aim of our …

Maternal immune responses during pregnancy are critical in programming the future health
of a newborn. The maternal immune system is required to accommodate fetal immune …

Antiphospholipid syndrome (APS) is an autoimmune thrombophilia characterized by
recurrent thrombotic events and/or pregnancy morbidity in the presence of antiphospholipid …

Anti-phospholipid syndrome (APS) is an autoimmune prothrombotic disorder characterised
by the predisposition to venous and/or arterial thrombosis and obstetric morbidity …

Our previous study demonstrated that Toll-like receptor 4 (TLR4) could act as a co-receptor
with annexin A2 (ANX2) mediating anti-β2-glycoprotein I/β2-glycoprotein I (anti-β 2 GPI/β 2 …